NWMP
CORT icon

Noble Wealth Management PBC’s Corcept Therapeutics CORT Stock Holding History

Noble Wealth Management PBC’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$783 Buy
+9
New +$543 ﹤0.01% 745

Other funds holding CORT

BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

Noble Wealth Management PBC's CORT Position: Q2 2026 in Review

Noble Wealth Management PBC opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 9 shares worth $783. The stake represents ﹤0.01% of the portfolio and ranks #745 among its holdings.

92 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Noble Wealth Management PBC held 9 shares of Corcept Therapeutics worth $783 as of Q2 2026.
  • Corcept Therapeutics was a new Noble Wealth Management PBC position in Q2 2026.
  • Corcept Therapeutics made up ﹤0.01% of Noble Wealth Management PBC's portfolio in Q2 2026, its #745 holding.
  • 92 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Noble Wealth Management PBC's 13F filing for Q2 2026, filed 1 Jul 2026.